Inhibition of Return in the Human 5HT2A Agonist and NMDA Antagonist Model of Psychosis

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neuropsychopharmacology

• Publication date

  2006-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/sj.npp.1300882PMID 16123739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of return

  2008cited by this paper
• Deficient inhibition of return in schizophrenia-further evidence from an independent sample.

  2006cited by this paper
• Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers

  2005cited by this paper
• Blunted inhibition of return in schizophrenia-evidence from a longitudinal study.

  2004cited by this paper
• An Event-related fMRI Study of Exogenous Orienting: Supporting Evidence for the Cortical Basis of Inhibition of Return?

  2004cited by this paper
• Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia.

  2004cited by this paper
• Neural networks underlying endogenous and exogenous visual-spatial orienting

  2004cited by this paper
• Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity

  2004cited by this paper
• Neural correlates of the automatic and goal-driven biases in orienting spatial attention.

  2004cited by this paper
• Altered effective connectivity during working memory performance in schizophrenia: a study with fMRI and structural equation modeling

  2003cited by this paper
• Delayed onset of inhibition of return in schizophrenia.

  2002cited by this paper
• Temporal Dynamics of Reflexive Attention Shifts: A Dual-Stream Rapid Serial Visual Presentation Exploration

  2002cited by this paper
• Effects of the Hallucinogen Psilocybin on Covert Orienting of Visual Attention in Humans

  2002cited by this paper
• Covert Reorienting and Inhibition of Return: An Event-Related fMRI Study

  2002cited by this paper
• Prefrontal neurons and the genetics of schizophrenia.

  2001cited by this paper
• Attentional asymmetry in schizophrenia: disengagement and inhibition of return deficits.

  2001cited by this paper
• Evidence for abnormal cortical functional connectivity during working memory in schizophrenia.

  2001cited by this paper
• Inhibition of return.

  2000cited by this paper
• Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers A Double-Blind, Placebo-Controlled PET Study with [18F]FDG

  1999cited by this paper
• Inhibition of return in spatial attention: direct evidence for collicular generation

  1999cited by this paper
• Neural Basis of Endogenous and Exogenous Spatial Orienting: A Functional MRI Study

  1999cited by this paper
• Inhibitory processing in visuospatial attention in healthy adults and schizophrenic patients.

  1999influential reference
• Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers Results of an experimental double-blind placebo-controlled study

  1999cited by this paper
• The schizophrenia ketamine challenge study debate.

  1999cited by this paper
• Spatial and semantic inhibitory processing in schizophrenia.

  1999influential reference
• Symptom provocation studies in psychiatric disorders: scientific value, risks, and future.

  1999cited by this paper
• "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?

  1998cited by this paper
• Distinguishing schizophrenic patients from healthy controls by quantitative measurement of eye movement parameters.

  1998cited by this paper
• Visual attention and symptoms in schizophrenia: a 1-year follow-up.

  1998cited by this paper
• On the causes and effects of inhibition of return

  1998cited by this paper
• Saccadic and attentional abnormalities in patients with schizophrenia

  1998cited by this paper
• Methodological issues of human experimental research with hallucinogens.

  1998cited by this paper
• History, rationale and potential of human experimental hallucinogenic drug research in psychiatry.

  1998cited by this paper
• Covert visual attention in patients with early-onset schizophrenia.

  1998cited by this paper
• The NMDA antagonist model for schizophrenia: promise and pitfalls.

  1998cited by this paper
• Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET).

  1997cited by this paper
• Lateralized attentional deficits in drug-free and medicated schizophrenic patients.

  1997influential reference
• Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis.

  1996cited by this paper
• Antisaccades and smooth pursuit eye movements in schizophrenia.

  1995cited by this paper
• Asymmetries in the covert orienting of visual spatial attention in schizophrenia.

  1995influential reference
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994cited by this paper
• Abnormalities in rapid, automatic aspects of attention in schizophrenia: blunted inhibition of return.

  1994cited by this paper
• DSM-IV: Diagnostic and Statistical Manual of Mental Disorders

  1994cited by this paper
• Attentional asymmetry in schizophrenia: the role of illness subtype and symptomatology.

  1994influential reference
• Deficits of the automatic orienting of attention in schizophrenic patients.

  1993cited by this paper
• Disengagement of attention in chronic schizophrenia.

  1992influential reference
• Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors.

  1992cited by this paper
• Attentional asymmetry in schizophrenia: controlled and automatic processes.

  1992cited by this paper
• Visual orienting in schizophrenia.

  1992cited by this paper
• Attentional cues in chronic schizophrenia: abnormal disengagement of attention.

  1992cited by this paper
• Gating and habituation of the startle reflex in schizophrenic patients.

  1992cited by this paper
• Recent advances in the phencyclidine model of schizophrenia.

  1991influential reference
• NMDA receptor related agents : biochemistry, pharmacology and behavior

  1991cited by this paper
• The chiral forms of ketamine as probes for NMDA receptor functions in humans

  1991cited by this paper
• Disengagement of attention in schizophrenia.

  1991cited by this paper
• Scale for the Assessment of Negative Symptoms (SANS)*

  1989influential reference
• Lateralized deficits in covert shifts of visual attention in chronic and never-medicated schizophrenics compared to normal controls

  1989influential reference
• Asymmetries in hemispheric control of attention in schizophrenia.

  1988influential reference
• Psychotogenic drugs as models for schizophrenia.

  1988cited by this paper
• Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence.

  1986cited by this paper
• Inhibition of return : Neural basis and function

  1985cited by this paper
• Eye movement dysfunctions and psychosis.

  1985cited by this paper
• Components of visual orienting

  1984cited by this paper

• Cognitive control as a transdiagnostic mechanism of action in psychedelic effects

  2025cites this paper
• Acute Effects and Long-Term Neuropsychological Consequences of Classic Psychedelics Use.

  2025cites this paper
• Hemispheric annealing and lateralization under psychedelics (HEALS): A novel hypothesis of psychedelic action in the brain

  2024cites this paper
• Clinically relevant acute subjective effects of psychedelics beyond mystical experience

  2024cites this paper
• Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis

  2024cites this paper
• Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors

  2024cites this paper
• Psychedelic Cognition—The Unreached Frontier of Psychedelic Science

  2022cites this paper
• Dose-response relationships of LSD-induced subjective experiences in humans

  2022cites this paper
• Pharmacological, Neural, and Psychological Mechanisms underlying Psychedelics: A Critical Review.

  2022cites this paper
• Neuropsychological Functioning in Users of Serotonergic Psychedelics – A Systematic Review and Meta-Analysis

  2021cites this paper
• Dissecting the shared genetic basis of migraine and mental disorders using novel statistical tools

  2021cites this paper
• Impaired inhibition of return during free-viewing behaviour in patients with schizophrenia

  2021cites this paper
• Models of psychedelic drug action: modulation of cortical-subcortical circuits.

  2021cites this paper
• References

  2021cites this paper
• Empirische Untersuchung veränderter Bewusstseinszustände

  2018cites this paper
• Crosstalk Between 5-HT2A and mGlu2 Receptors: Implications in Schizophrenia and Its Treatment

  2018cites this paper
• Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition

  2018cites this paper
• A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans.

  2017influential citation
• Neuropharmacology of N,N-dimethyltryptamine.

  2016cites this paper
• Empirische Untersuchung veränderter Bewusstseinszustände: Definition, Quantifizierung und Forschungsperspektiven

  2016cites this paper
• Brain site- and transmitter-dependent actions of methamphetamine, morphine and antipsychotics.

  2016cites this paper
• eview europharmacology of N , N-dimethyltryptamine heresa

  2016cites this paper
• Psychedelic therapy from an existential psychological viewpoint : a theoretical analysis

  2016cites this paper
• S-ketamine influences strategic allocation of attention but not exogenous capture of attention.

  2015cites this paper
• Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?

  2014cites this paper
• Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users

  2013cites this paper
• Neuromodulation of Olfactory Learning by Serotonergic Signaling at Glomerular Synapses Reveals a Peripheral Sensory Gating Mechanism

  2012cites this paper
• Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice

  2012cites this paper
• On the measurement of the effects of alcohol and illicit substances on inhibition of return

  2012cites this paper
• Use of cannabis enhances attentional inhibition

  2012cites this paper
• Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers

  2012cites this paper
• Auditory orienting and inhibition of return in schizophrenia: a functional magnetic resonance imaging study.

  2012cites this paper
• Neuropsychedelia: The Revival of Hallucinogen Research since the Decade of the Brain

  2012cites this paper
• Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention

  2010cites this paper
• Association between Serotonin-Related Polymorphisms in 5HT2A, TPH1, TPH2 Genes and Bipolar Disorder in Korean Population

  2010cites this paper
• Glutamatergic Approaches to the Conceptualization and Treatment of Schizophrenia

  2009cites this paper
• Identification of a Novel Serotonin / Glutamate Receptor Complex Implicated in Psychosis

  2009cites this paper
• The psychotomimetic effects of PCP , LSD and MDMA : Pharmacological models of schizophrenia ?

  2009influential citation
• Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines

  2009cites this paper
• Handbook of neurochemistry and molecular neurobiology, schizophrenia

  2009cites this paper
• Human hallucinogen research: guidelines for safety

  2008influential citation
• Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis

  2008influential citation
• S‐ketamine and GABA‐A‐receptor interaction in humans: an exploratory study with I‐123‐iomazenil SPECT

  2008cites this paper
• [Inhibition of return in schizophrenia: a review].

  2008cites this paper
• Hallucinations: The Science of Idiosyncratic Perception

  2008cites this paper
• Identification of a serotonin/glutamate receptor complex implicated in psychosis

  2008cites this paper
• Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis

  2008cites this paper
• Kognition bei Modellpsychosen

  2008cites this paper
• Cajal and brain plasticity: insights relevant to emerging concepts of mind.

  2007cites this paper
• Neurophysiologic correlates to sensory and cognitive processing in altered states of consciousness

  2007cites this paper
• DMT at fifty.

  2007cites this paper
• Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis

  2007cites this paper
• Beringer ’ s experiential model of psychosis The idea of mimicking a mental disorder by administering a drug goes back to the French psychiatrist

  2006cites this paper
• Ceci n’est pas une psychose. Toward a Historical Epistemology of Model Psychoses

  2006cites this paper
• An Event-related fMRI Study of Exogenous Orienting: Supporting Evidence for the Cortical Basis of Inhibition of Return?

  2004cites this paper